These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 25022707)

  • 21. A typical pattern of the labial arteries with implication for lip augmentation with injectable fillers.
    Tansatit T; Apinuntrum P; Phetudom T
    Aesthetic Plast Surg; 2014 Dec; 38(6):1083-9. PubMed ID: 25355551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
    Neudecker BA; Stern R; Connolly MK
    Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyaluronidase Caveats in Treating Filler Complications.
    Landau M
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S347-53. PubMed ID: 26618463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anatomic location of hyaluronic acid filler material injected into nasolabial fold: a histologic study.
    Arlette JP; Trotter MJ
    Dermatol Surg; 2008 Jun; 34 Suppl 1():S56-62; discussion S62-3. PubMed ID: 18547183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doppler Ultrasound in the Management of Vascular Complications Associated with Hyaluronic Acid Dermal Fillers.
    Munia MA; Munia CG; Parada MB; Ben-Hurferraz Parente J; Wolosker N
    J Clin Aesthet Dermatol; 2022 Feb; 15(2):40-43. PubMed ID: 35309877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The science of hyaluronic acid dermal fillers.
    Tezel A; Fredrickson GH
    J Cosmet Laser Ther; 2008 Mar; 10(1):35-42. PubMed ID: 18330796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo Degradation of Crosslinked Hyaluronic Acid Fillers by Exogenous Hyaluronidases.
    Shumate GT; Chopra R; Jones D; Messina DJ; Hee CK
    Dermatol Surg; 2018 Aug; 44(8):1075-1083. PubMed ID: 29659410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blindness After Facial Filler Injections: The Role of Extravascular Hyaluronidase on Intravascular Hyaluronic Acid Embolism in the Rabbit Experimental Model.
    Zhang L; Feng X; Shi H; Wu WTL; Wu S
    Aesthet Surg J; 2020 Feb; 40(3):319-326. PubMed ID: 31630161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers.
    Rao V; Chi S; Woodward J
    J Drugs Dermatol; 2014 Sep; 13(9):1053-6. PubMed ID: 25226005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study.
    Baumann LS; Shamban AT; Lupo MP; Monheit GD; Thomas JA; Murphy DK; Walker PS;
    Dermatol Surg; 2007 Dec; 33 Suppl 2():S128-35. PubMed ID: 18086050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of hyaluronic acid fillers by in vitro and in vivo testing.
    Park KY; Kim HK; Kim BJ
    J Eur Acad Dermatol Venereol; 2014 May; 28(5):565-8. PubMed ID: 23495913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of Intracellular Hyaluronidase Isoform by Degradable Nanoassembly Coupled with RNA-Binding Fluorescence Amplification.
    Li Y; Yang S; Guo L; Xiao Y; Luo J; Li Y; Wong MS; Yang R
    Anal Chem; 2019 May; 91(10):6887-6893. PubMed ID: 30990018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations.
    Smith KC
    Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Intra-arterial Hyaluronidase Infusion for Ophthalmic Artery Occlusion Following Cosmetic Facial Filler (Hyaluronic Acid) Injection.
    Oh BL; Jung C; Park KH; Hong YJ; Woo SJ
    Neuroophthalmology; 2014; 38(1):39-43. PubMed ID: 27928273
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Zerbinati N; Mocchi R; Galadari H; Maccario C; Maggi M; Rauso R; Passi A; Esposito C; Sommatis S
    Biomed Res Int; 2019; 2019():3196723. PubMed ID: 31309104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed allergic hypersensitivity to hyaluronidase during the treatment of granulomatous hyaluronic acid reactions.
    Wu L; Liu X; Jian X; Wu X; Xu N; Dou X; Yu B
    J Cosmet Dermatol; 2018 Dec; 17(6):991-995. PubMed ID: 29159865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of the vascular interstitial matrix to induced contraction by angiotensin II. In vitro studies on the rabbit aorta, mesenteric artery and vein].
    Plante GE; Lamontagne F; Sirois P
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):997-1001. PubMed ID: 8949367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2).
    Emer J; Sundaram H
    J Drugs Dermatol; 2013 Dec; 12(12):1345-54. PubMed ID: 24301235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronan content of Wharton's jelly in healthy and Down syndrome fetuses.
    Raio L; Cromi A; Ghezzi F; Passi A; Karousou E; Viola M; Vigetti D; De Luca G; Bolis P
    Matrix Biol; 2005 Apr; 24(2):166-74. PubMed ID: 15890266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of hyaluronic acid and hyaluronidase-1 in obstructive sleep apnoea.
    Meszaros M; Kis A; Kunos L; Tarnoki AD; Tarnoki DL; Lazar Z; Bikov A
    Sci Rep; 2020 Nov; 10(1):19484. PubMed ID: 33173090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.